NewCardio Financial Statements From 2010 to 2026
| NWCI Stock | USD 0.0001 0.00 0.00% |
Check NewCardio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among NewCardio's main balance sheet or income statement drivers, such as , as well as many indicators such as . NewCardio financial statements analysis is a perfect complement when working with NewCardio Valuation or Volatility modules.
NewCardio | Build AI portfolio with NewCardio Stock |
NewCardio Company Return On Asset Analysis
NewCardio's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current NewCardio Return On Asset | -2.24 |
Most of NewCardio's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, NewCardio is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, NewCardio has a Return On Asset of -2.2419. This is 74.38% lower than that of the Health Care Technology sector and 87.61% lower than that of the Health Care industry. The return on asset for all United States stocks is notably higher than that of the company.
NewCardio Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining NewCardio's current stock value. Our valuation model uses many indicators to compare NewCardio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across NewCardio competition to find correlations between indicators driving NewCardio's intrinsic value. More Info.NewCardio is rated below average in return on asset category among its peers. It is rated below average in operating margin category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the NewCardio's earnings, one of the primary drivers of an investment's value.About NewCardio Financial Statements
Investors use fundamental indicators, such as NewCardio's revenue or net income, to determine how well the company is positioned to perform in the future. Although NewCardio's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
NewCardio, Inc., a cardiac diagnostic and services company, focuses on the research, development, and commercialization of proprietary software platform technology solutions for the non-invasive diagnosis and monitoring of cardiovascular disease , as well as the cardiac safety assessment of drugs under development. NewCardio, Inc. was founded in 2004 and is based in Branchburg, New Jersey. EINSTEIN NOAH is traded on NASDAQ Exchange in the United States.
Currently Active Assets on Macroaxis
When determining whether NewCardio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of NewCardio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Newcardio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Newcardio Stock:Check out the analysis of NewCardio Correlation against competitors. For more detail on how to invest in NewCardio Stock please use our How to Invest in NewCardio guide.You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NewCardio. If investors know NewCardio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NewCardio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of NewCardio is measured differently than its book value, which is the value of NewCardio that is recorded on the company's balance sheet. Investors also form their own opinion of NewCardio's value that differs from its market value or its book value, called intrinsic value, which is NewCardio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NewCardio's market value can be influenced by many factors that don't directly affect NewCardio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NewCardio's value and its price as these two are different measures arrived at by different means. Investors typically determine if NewCardio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NewCardio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.